Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Diabetes Therapeutics and Diagnostics Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Insulin
      • 1.3.3 Insulin Delivery
      • 1.3.4 Oral Hypoglycemic Drugs
      • 1.3.5 Diagnosis And Monitoring
      • 1.3.6 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Diabetes Therapeutics and Diagnostics Market Share by Application (2019-2025)
      • 1.4.2 Type 1 Diabetes
      • 1.4.3 Type 2 Diabetes
      • 1.4.4 Gestational Diabetes
      • 1.4.5 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Diabetes Therapeutics and Diagnostics Market Size
      • 2.1.1 Global Diabetes Therapeutics and Diagnostics Revenue 2014-2025
      • 2.1.2 Global Diabetes Therapeutics and Diagnostics Sales 2014-2025
    • 2.2 Diabetes Therapeutics and Diagnostics Growth Rate by Regions
      • 2.2.1 Global Diabetes Therapeutics and Diagnostics Sales by Regions 2014-2019
      • 2.2.2 Global Diabetes Therapeutics and Diagnostics Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Diabetes Therapeutics and Diagnostics Sales by Manufacturers
      • 3.1.1 Diabetes Therapeutics and Diagnostics Sales by Manufacturers 2014-2019
      • 3.1.2 Diabetes Therapeutics and Diagnostics Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Diabetes Therapeutics and Diagnostics Revenue by Manufacturers (2014-2019)
      • 3.2.2 Diabetes Therapeutics and Diagnostics Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Diabetes Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.3 Diabetes Therapeutics and Diagnostics Price by Manufacturers
    • 3.4 Key Manufacturers Diabetes Therapeutics and Diagnostics Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Diabetes Therapeutics and Diagnostics Market
    • 3.6 Key Manufacturers Diabetes Therapeutics and Diagnostics Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Insulin Sales and Revenue (2014-2019)
      • 4.1.2 Insulin Delivery Sales and Revenue (2014-2019)
      • 4.1.3 Oral Hypoglycemic Drugs Sales and Revenue (2014-2019)
      • 4.1.4 Diagnosis And Monitoring Sales and Revenue (2014-2019)
      • 4.1.5 Others Sales and Revenue (2014-2019)
    • 4.2 Global Diabetes Therapeutics and Diagnostics Sales Market Share by Type
    • 4.3 Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Type
    • 4.4 Diabetes Therapeutics and Diagnostics Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Diabetes Therapeutics and Diagnostics Sales by Application

    6 United States

    • 6.1 United States Diabetes Therapeutics and Diagnostics Breakdown Data by Company
    • 6.2 United States Diabetes Therapeutics and Diagnostics Breakdown Data by Type
    • 6.3 United States Diabetes Therapeutics and Diagnostics Breakdown Data by Application

    7 European Union

    • 7.1 European Union Diabetes Therapeutics and Diagnostics Breakdown Data by Company
    • 7.2 European Union Diabetes Therapeutics and Diagnostics Breakdown Data by Type
    • 7.3 European Union Diabetes Therapeutics and Diagnostics Breakdown Data by Application

    8 China

    • 8.1 China Diabetes Therapeutics and Diagnostics Breakdown Data by Company
    • 8.2 China Diabetes Therapeutics and Diagnostics Breakdown Data by Type
    • 8.3 China Diabetes Therapeutics and Diagnostics Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Diabetes Therapeutics and Diagnostics Breakdown Data by Company
    • 9.2 Rest of World Diabetes Therapeutics and Diagnostics Breakdown Data by Type
    • 9.3 Rest of World Diabetes Therapeutics and Diagnostics Breakdown Data by Application
    • 9.4 Rest of World Diabetes Therapeutics and Diagnostics Breakdown Data by Countries
      • 9.4.1 Rest of World Diabetes Therapeutics and Diagnostics Sales by Countries
      • 9.4.2 Rest of World Diabetes Therapeutics and Diagnostics Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 77 Elektronika Kft.
      • 10.1.1 77 Elektronika Kft. Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Diabetes Therapeutics and Diagnostics
      • 10.1.4 Diabetes Therapeutics and Diagnostics Product Introduction
      • 10.1.5 77 Elektronika Kft. Recent Development
    • 10.2 A. Menarini Diagnostics S.R.L
      • 10.2.1 A. Menarini Diagnostics S.R.L Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Diabetes Therapeutics and Diagnostics
      • 10.2.4 Diabetes Therapeutics and Diagnostics Product Introduction
      • 10.2.5 A. Menarini Diagnostics S.R.L Recent Development
    • 10.3 Abbott Laboratories
      • 10.3.1 Abbott Laboratories Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Diabetes Therapeutics and Diagnostics
      • 10.3.4 Diabetes Therapeutics and Diagnostics Product Introduction
      • 10.3.5 Abbott Laboratories Recent Development
    • 10.4 Agamatrix Inc.
      • 10.4.1 Agamatrix Inc. Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Diabetes Therapeutics and Diagnostics
      • 10.4.4 Diabetes Therapeutics and Diagnostics Product Introduction
      • 10.4.5 Agamatrix Inc. Recent Development
    • 10.5 Animas Corp.
      • 10.5.1 Animas Corp. Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Diabetes Therapeutics and Diagnostics
      • 10.5.4 Diabetes Therapeutics and Diagnostics Product Introduction
      • 10.5.5 Animas Corp. Recent Development
    • 10.6 Ascensia
      • 10.6.1 Ascensia Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Diabetes Therapeutics and Diagnostics
      • 10.6.4 Diabetes Therapeutics and Diagnostics Product Introduction
      • 10.6.5 Ascensia Recent Development
    • 10.7 Becton Dickinson
      • 10.7.1 Becton Dickinson Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Diabetes Therapeutics and Diagnostics
      • 10.7.4 Diabetes Therapeutics and Diagnostics Product Introduction
      • 10.7.5 Becton Dickinson Recent Development
    • 10.8 Debiotech S.A.
      • 10.8.1 Debiotech S.A. Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Diabetes Therapeutics and Diagnostics
      • 10.8.4 Diabetes Therapeutics and Diagnostics Product Introduction
      • 10.8.5 Debiotech S.A. Recent Development
    • 10.9 Eli Lilly And Co.
      • 10.9.1 Eli Lilly And Co. Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Diabetes Therapeutics and Diagnostics
      • 10.9.4 Diabetes Therapeutics and Diagnostics Product Introduction
      • 10.9.5 Eli Lilly And Co. Recent Development
    • 10.10 Glaxo Smithkline
      • 10.10.1 Glaxo Smithkline Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Diabetes Therapeutics and Diagnostics
      • 10.10.4 Diabetes Therapeutics and Diagnostics Product Introduction
      • 10.10.5 Glaxo Smithkline Recent Development
    • 10.11 Inlight Solutions Inc.
    • 10.12 Johnson & Johnson
    • 10.13 Lifescan Inc.
    • 10.14 Medtronic
    • 10.15 Merck & Co.
    • 10.16 Merck KGAA
    • 10.17 Nipro Corp.
    • 10.18 Novartis Pharma Ag
    • 10.19 Novo Nordisk A/S
    • 10.20 Owen Mumford Ltd.
    • 10.21 Palco Labs Inc.
    • 10.22 Roche
    • 10.23 Sanofi
    • 10.24 Takeda Pharmaceutical Co. Ltd.
    • 10.25 Terumo Corp.

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Diabetes Therapeutics and Diagnostics Sales Channels
      • 11.2.2 Diabetes Therapeutics and Diagnostics Distributors
    • 11.3 Diabetes Therapeutics and Diagnostics Customers

    12 Market Forecast

    • 12.1 Global Diabetes Therapeutics and Diagnostics Sales and Revenue Forecast 2019-2025
    • 12.2 Global Diabetes Therapeutics and Diagnostics Sales Forecast by Type
    • 12.3 Global Diabetes Therapeutics and Diagnostics Sales Forecast by Application
    • 12.4 Diabetes Therapeutics and Diagnostics Forecast by Regions
      • 12.4.1 Global Diabetes Therapeutics and Diagnostics Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Diabetes Therapeutics and Diagnostics Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
      In 2019, the market size of Diabetes Therapeutics and Diagnostics is 128000 million US$ and it will reach 180600 million US$ in 2025, growing at a CAGR of 4.4% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Diabetes Therapeutics and Diagnostics.

      This report studies the global market size of Diabetes Therapeutics and Diagnostics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Diabetes Therapeutics and Diagnostics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      77 Elektronika Kft.
      A. Menarini Diagnostics S.R.L
      Abbott Laboratories
      Agamatrix Inc.
      Animas Corp.
      Ascensia
      Becton Dickinson
      Debiotech S.A.
      Eli Lilly And Co.
      Glaxo Smithkline
      Inlight Solutions Inc.
      Johnson & Johnson
      Lifescan Inc.
      Medtronic
      Merck & Co.
      Merck KGAA
      Nipro Corp.
      Novartis Pharma Ag
      Novo Nordisk A/S
      Owen Mumford Ltd.
      Palco Labs Inc.
      Roche
      Sanofi
      Takeda Pharmaceutical Co. Ltd.
      Terumo Corp.

      Market Segment by Product Type
      Insulin
      Insulin Delivery
      Oral Hypoglycemic Drugs
      Diagnosis And Monitoring
      Others

      Market Segment by Application
      Type 1 Diabetes
      Type 2 Diabetes
      Gestational Diabetes
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Diabetes Therapeutics and Diagnostics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Diabetes Therapeutics and Diagnostics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Diabetes Therapeutics and Diagnostics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now